| Affymax to Present at RBC Capital Markets Healthcare Conference - PharmaLive.com (press release) |
|
|
Affymax's product candidate, Hematide™, is currently in Phase 3 clinical trials for the treatment of anemia associated with chronic renal failure. ... |